Replies to post #52200 on Innovation Pharmaceuticals Inc (IPIX)

[grizzlyman]

this thing would be at 1.40 if aspire would be selling, there is no large block selling, just a few frantic retail sellers selling small amount of shares, the company is funded from the last systematic share sales months ago. The company gonna wait as long as possible to sell new aspire shares because I am sure they think this will be much higher by the time time they need more cash, therefore less dilution

[noretreat]

After talking with an Aspire principal last week, it is apparent that their going in strategy is accumulation. This is true across several companies and if you research their investments you will see SEC form 13g reports revealing some of their positions. I'm not saying they are in a strict buy and hold mode, but that is clearly what they want to do when they partner with a company. Conditions and outlooks do change, however, and I'm sure their strategy can change as well. At least one person at Aspire is enthusiastic about CTIX' prospects.

We can calculate (guess) when that accumulation will reach 5% of CTIX and require reporting. Using a (hypothetical) o/s of 120 million they would need to report when they are holding 6 million shares, or 5% of the total. If their average price is 2 bucks (in reality maybe $1.70), that would be a $12 million investment. I believe they would have 30 days to report their position.

My guess is that we could see a report in a few months.